Structure Therapeutics
An Associate Director of Active Pharmaceutical Ingredient (API) at Structure Therapeutics oversees small molecule API development for CMC projects, managing drug substance activities in CDMOs to ensure high-quality results and regulatory compliance.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2017
Structure Therapeutics is a biopharmaceutical company with the mission 'Medicine is our platform. Accessibility is our cure.' The company is focused on developing medicines with an emphasis on accessibility, and maintains an active pipeline and team as indicated on its website.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Structure Therapeutics.
Structure Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Senior Director, API Development
8a7882525b6027b0015b692822e001ab
Director, CMC – Small Molecule Chemistry
Pathos
Senior Director, Regulatory Affairs CMC
Zenas BioPharma
Senior Director, Analytical Development, CMC Small Molecule
Centessa Pharmaceuticals
Associate Director, Regulatory Affairs CMC
Acadia Pharmaceuticals Inc.
Postdoctoral Scholar
Chick-fil-A